Locus Pharmaceuticals

company

About

Locus Pharmaceuticals develops a drug design and development platform for oral drug therapies in the areas of unmet medical needs.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$42.75M
Industries
Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 1998
Number Of Employee
51 - 100
Operating Status
Active

Locus Pharmaceuticals, Inc. develops a drug design and development platform for oral drug therapies in the areas of unmet medical needs. Its fragment-based computational drug design technology is used for the discovery and development of compounds for the treatment of unmet medical needs. The company has a computational drug design technology, which is used to develop a pipeline of drug development candidates, including direct and allosteric kinase inhibitors for cancer and inflammation diseases. Locus Pharmaceuticals, Inc. was formerly known as Locus Discovery, Inc. The company was incorporated in 1998 and is based in Blue Bell, Pennsylvania. Locus Pharmaceuticals, Inc. is a former subsidiary of Sarnoff Corporation.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$82.75M
Locus Pharmaceuticals has raised a total of $82.75M in funding over 2 rounds. Their latest funding was raised on Nov 7, 2001 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 7, 2001 Series C $40M 1 Detail
Nov 28, 2000 Series B $42.75M 1 Cooper Hill Partners Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Locus Pharmaceuticals is funded by 1 investors. Cooper Hill Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Cooper Hill Partners Series C